Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code
x Close Forever Close
Volume 22 Issue 3
. 
Turn off MathJax
Article Contents
Article Navigation >  Journal of Pharmaceutical Practice and Service  > 2004  >  (3): 138-140

LIU Li-hua, OU Zhou-luo, Zhu, Chun-fang. Therapeutic effect of a new liposome-prednisolone on the puromycin aminonucleoside nephropathy in rats[J]. Journal of Pharmaceutical Practice and Service, 2004, (3): 138-140.
Citation: LIU Li-hua, OU Zhou-luo, Zhu, Chun-fang. Therapeutic effect of a new liposome-prednisolone on the puromycin aminonucleoside nephropathy in rats[J]. Journal of Pharmaceutical Practice and Service, 2004, (3): 138-140.
shu

Therapeutic effect of a new liposome-prednisolone on the puromycin aminonucleoside nephropathy in rats

  • 1.

    Department of Biochemistry and Molecular Biology, Shanghai Medical College, Fudan University, Shanghai 200032, China;Department of Biochemistry, Medical College, Shaoxing College of Arts and Sciences, Shaoxing 312000, China

  • 2.

    Department of Biochemistry and Molecular Biology, Shanghai Medical College, Fudan University, Shanghai 200032, China

  • Received Date: 2003-12-29
  • Objective To observe the effect of a novel liposome-prednisolone on puromycin aminonucleoside (PAN) nephropathy model in rats. Methods 160～180g BW male Wistar rats were used in this experiment. The rats were given a single injection of PAN at the dose of 4mg/100g BW through right jugular vein to establish the nephrotic syndrome (NS) model. The free prednisolone (PRED) treated group were given (i.p.) the free prednisolone at the dose of 2.0mg/100g BW and the liposome prednisolone (Lipo-PRED) treated group were given (i.v.) the liposome prednisolone at the dose of 1.5mg/100g BW. Urinary protein excretion examined with the biuret method and the monocyte/macrophage, CD4+ T cells and CD8+T cells were analyzed by immunohistochemistry. Results The proteinuria of the Lipo-PRED treated group reduced; the infiltration of monocyte/macrophages, CD4+T cells and CD8+T cells in the glomeruli and interstitium also remarkably weakened. Conclusion The liposome prednisolone can remarkably reduce the proteinuria excretion and leukocyte infiltration both in the glomeruli and tubulointerstitium in the PAN model.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Get Citation
PDF
XML

Article Metrics

Article views(2118) PDF downloads(876) Cited by()

Related
Proportional views

Therapeutic effect of a new liposome-prednisolone on the puromycin aminonucleoside nephropathy in rats

  • 1. Department of Biochemistry and Molecular Biology, Shanghai Medical College, Fudan University, Shanghai 200032, China;Department of Biochemistry, Medical College, Shaoxing College of Arts and Sciences, Shaoxing 312000, China
  • 2. Department of Biochemistry and Molecular Biology, Shanghai Medical College, Fudan University, Shanghai 200032, China
  • Received Date: 2003-12-29

Abstract: Objective To observe the effect of a novel liposome-prednisolone on puromycin aminonucleoside (PAN) nephropathy model in rats. Methods 160～180g BW male Wistar rats were used in this experiment. The rats were given a single injection of PAN at the dose of 4mg/100g BW through right jugular vein to establish the nephrotic syndrome (NS) model. The free prednisolone (PRED) treated group were given (i.p.) the free prednisolone at the dose of 2.0mg/100g BW and the liposome prednisolone (Lipo-PRED) treated group were given (i.v.) the liposome prednisolone at the dose of 1.5mg/100g BW. Urinary protein excretion examined with the biuret method and the monocyte/macrophage, CD4+ T cells and CD8+T cells were analyzed by immunohistochemistry. Results The proteinuria of the Lipo-PRED treated group reduced; the infiltration of monocyte/macrophages, CD4+T cells and CD8+T cells in the glomeruli and interstitium also remarkably weakened. Conclusion The liposome prednisolone can remarkably reduce the proteinuria excretion and leukocyte infiltration both in the glomeruli and tubulointerstitium in the PAN model.

LIU Li-hua, OU Zhou-luo, Zhu, Chun-fang. Therapeutic effect of a new liposome-prednisolone on the puromycin aminonucleoside nephropathy in rats[J]. Journal of Pharmaceutical Practice and Service, 2004, (3): 138-140.
Citation: LIU Li-hua, OU Zhou-luo, Zhu, Chun-fang. Therapeutic effect of a new liposome-prednisolone on the puromycin aminonucleoside nephropathy in rats[J]. Journal of Pharmaceutical Practice and Service, 2004, (3): 138-140.
shu

    HTML

Catalog

    版权所有：《药学实践与服务》编辑委员会

    Supervisor & Sponsors: Address: No 325 Guohe Road, ShanghaiPost Code: 200433

    Tel: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    Supported by: Beijing Renhe Information Technology Co., Ltd.  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return